J&J Proposes $6.5B Deal To End Ovarian Cancer Claims

By Carolina Bolado · May 1, 2024, 11:36 AM EDT

Johnson & Johnson said Wednesday it is proposing a prepackaged reorganization plan for its talc unit that will pay out $6.5 billion to resolve claims that its talc-based baby powder caused ovarian...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Carolina

April 15, 2024
FTX Liquidators Describe Operating Blindly In Initial Days
April 04, 2024
Surfside, Fla., Condo Collapse Victims To Get Additional $4.8M
March 18, 2024
Voyager Investors Suing Mark Cuban Seek Class Cert.
March 13, 2024
Judge Says Air Purifier Co. Risks $13M Claim Without Counsel
February 26, 2024
11th Circ. Says Bankruptcy Fraud Threat Can't Tank Deal
February 02, 2024
Foreign Liquidators Say SEC Plan Is Counter To Cayman Law
January 26, 2024
Piper Aircraft Asks Fla. Court To Modify Claims Trust
August 31, 2023
Attys Win $2.5M Fee Award in $63M Real Estate Investor Suit
August 14, 2023
3rd-Party Releases In Ch. 11 May Die At Supreme Court
July 19, 2023
Endo Pitches Deal With Distributors Over Ch. 11 Sale Plan